Table 1.

Patient characteristics at baseline

Characteristicn (range), n = 15%
Median age68 (52-78)
Median PSA261 (46-1705)
Median Gleason score8 (5-10)
Median hemoglobin11.6 (9.3-14.3)
Median alkaline phosphate154 (52-323)
Median days since last chemotherapy91 (28-925)
Performance status
    0427
    11067
    216
Receiving concurrent zoledronic acid
    Yes960
    No640
Race
    White1280
    Black320
Hypercalcemia
    No15100
Prostatectomy
    Yes533
    No1067
Chemotherapy
    Taxane based1387
    Other213
Radiation therapy
    Yes1280
    No320
Androgen ablation
    Yes1493
    No17
Other treatment
    Yes960
    No640
Site of disease (visceral)
    Yes640
    No960
Site of disease (bone)
    Yes1173
    No427
Site of disease (soft tissue)
    Yes427
    No1173
Other site
    Yes960
    No640
Disease status
    Measurable213
    Measurable and evaluable960
    Evaluable, not measurable427